On immunohistochemistry, the tumor cells were diffusely positive for B cell markers CD20 (Fig. 3B), and negative for CD21, CD3, CD34, CD5, Cytokeratin, Vimentin, CD21, CA9, CgA, CR and inhibin. Here, CR2 is linked to neoplasm.